Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 2 Uterine Prolapse 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Menstruation Disturbances 1 Leiomyoma 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Endometriosis 1 Endometrial Hyperplasia 1 Carcinoma, Endometrioid 1 Adenomyosis 1

Interventions

Specimen Handling 3 olaparib 2 durvalumab 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 serabelisib 1 sapanisertib 1 defactinib 1 ceralasertib 1 cediranib 1 capivasertib 1 cabozantinib 1 Restraint, Physical 1 RO5126766 1 Paclitaxel 1 Immunoglobulin G 1 Hysterectomy 1 Fluid Therapy 1 Disulfides 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Endometrioid × Hysterectomy × 1 year × Clear all

NCT02598219 2026-03-18

SENTIRAD

Centre Oscar Lambret

Phase 3 Active not recruiting

Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡